-
FDA authorizes a new liver safety biomarker relevant for Duchenne and Becker
We congratulate C-PATH (Critical Path Institute) on their success in getting the FDA to qualify […]
-
Insmed’s ASCEND Study and INS1201, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
Watch Webinar HERE The post Insmed’s ASCEND Study and INS1201, an Investigational Gene Therapy for […]
-
FDA approves new safety warning and updated prescribing information for Sarepta’s Elevidys
The FDA has approved the new labeling information Sarepta provided for Elevidys, Sarepta’s gene therapy […]
-
Progress Now: Immunotherapy Study Recruiting, Drug Cleared for Expanded Access, and More
Amyotrophic lateral sclerosis (ALS) Immunotherapy Study Recruiting Coya Therapeutics has launched the phase 2 ALSTARS […]
-
New Year, New Financial Plan: Tips to Get Your Budget Back On Track
For many families living with neuromuscular diseases, balancing health and disability-related expenses with rising household […]
-
Understanding Spinal-Bulbar Muscular Atrophy
Spinal-bulbar muscular atrophy (SBMA) is a genetic disorder that affects muscles and nerves, leading to […]
-
From Classroom to Courtroom: How Eric Arnold Navigated Accessibility in His Education and Career
Eric Arnold has built his life around sharing his skills and expertise with others — […]
-
A Lifetime of Learning: From college to a Career in Disability Advocacy
I’ve always known that I love to learn. That passion has taken me places I […]
-
The week we ran out of our emotional ‘leftovers’
When I was a young mom watching my oldest daughter, Lexi, move from upper elementary […]
-
The Hidden Power of Self-Care in Caregiving
Caregivers often give so much of themselves that sometimes their own needs fade into the […]
